Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Matas‐Céspedes, Alba
22  Ergebnisse:
Personensuche X
?
1

Use of human splenocytes in an innovative humanised mouse m..:

Matas‐Céspedes, Alba ; Brown, Lee ; Mahbubani, Krishnaa T...
Clinical & Translational Immunology.  9 (2020)  11 - p. , 2020
Link: https://doi.org/10.1002/..
 
?
2

Characterization of a novel potency endpoint for the evalua..:

Matas-Céspedes, Alba ; Lapointe, Jean-Martin ; Elder, Matthew J....
Frontiers in Immunology.  14 (2023)  - p. , 2023
Link: https://doi.org/10.3389/..
 
?
3

3D Model Characterization by 2D and 3D Imaging in t(14;18)-..:

Gava, Fabien ; Faria, Carla ; Gravelle, Pauline...
Cancers.  13 (2021)  7 - p. 1490 , 2021
Link: https://doi.org/10.3390/..
 
?
4

The receptor of the colony-stimulating factor-1 (CSF-1R) is..:

Valero, Juan Garcia ; Matas-Céspedes, Alba ; Arenas, Fabián...
Leukemia.  35 (2021)  9 - p. 2635-2649 , 2021
Link: https://doi.org/10.1038/..
 
?
5

Modeling human tumor-immune environments in vivo for the pr..:

Bareham, Bethany ; Georgakopoulos, Nikitas ; Matas-Céspedes, Alba..
Cancer Immunology, Immunotherapy.  70 (2021)  10 - p. 2737-2750 , 2021
Link: https://doi.org/10.1007/..
 
?
6

PI3Kδ inhibition reshapes follicular lymphoma–immune microe..:

Serrat, Neus ; Guerrero-Hernández, Martina ; Matas-Céspedes, Alba...
Blood Advances.  4 (2020)  17 - p. 4217-4231 , 2020
Link: https://doi.org/10.1182/..
 
?
7

Recent Advancements and Applications of Human Immune System..:

Curran, Michelle ; Mairesse, Maelle ; Matas-Céspedes, Alba...
Toxicologic Pathology.  48 (2019)  2 - p. 302-316 , 2019
Link: https://doi.org/10.1177/..
 
?
8

Use of human splenocytes in an innovative humanised mouse m..:

Matas‐Céspedes, Alba ; Brown, Lee ; Mahbubani, Krishnaa T...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7641894/.  , 2020
Link: http://www.ncbi.nlm.nih...
 
?
9

Characterization of a novel potency endpoint for the evalua..:

Alba Matas-Céspedes ; Jean-Martin Lapointe ; Matthew J. Elder...
https://www.frontiersin.org/articles/10.3389/fimmu.2023.1107848/full.  , 2023
Link: https://doi.org/10.3389/..
 
?
10

Table_1_Characterization of a novel potency endpoint for th..:

Alba Matas-Céspedes ; Jean-Martin Lapointe ; Matthew J. Elder...
doi:10.3389/fimmu.2023.1107848.s002.  , 2023
Link: https://doi.org/10.3389/..
 
?
11

DataSheet_1_Characterization of a novel potency endpoint fo..:

Alba Matas-Céspedes ; Jean-Martin Lapointe ; Matthew J. Elder...
doi:10.3389/fimmu.2023.1107848.s001.  , 2023
Link: https://doi.org/10.3389/..
 
?
12

3D Model Characterization by 2D and 3D Imaging in t(14;18)-..:

Fabien Gava ; Carla Faria ; Pauline Gravelle...
Methods and Technologies Development.  , 2021
Link: https://doi.org/10.3390/..
 
?
13

3D Model Characterization by 2D and 3D Imaging in t(14;18)-..:

Gava, Fabien ; Faria, Carla ; Gravelle, Pauline...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8036410/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
14

Modeling human tumor-immune environments in vivo for the pr..:

Bareham, Bethany ; Georgakopoulos, Nikitas ; Matas-Céspedes, Alba..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8423639/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
15

The receptor of the colony-stimulating factor-1 (CSF-1R) is..:

Valero, Juan Garcia ; Matas-Céspedes, Alba ; Arenas, Fabián...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8410584/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
1-15